With an estimated 10 million Americans experimenting with microdosing, a new training model aims to raise the bar on safety, ethics, and real-world results—plus what Virginia residents should know.

Athletes report flow, less pain, and sharper focus on mushrooms, LSD, and ketamine—but the science is thin. Here’s what research suggests, key risks, and DMV-specific guidance.

New preclinical data suggests whole-mushroom extracts may drive stronger, longer neuroplastic effects than lab-made psilocybin alone—echoing cannabis’s entourage effect.

Johnson & Johnson leads an $85 million Series C round for Delix Therapeutics, signaling growing corporate interest in novel therapies.

Cannabis and memory have a complicated relationship. This article unravels what research says about how THC affects recall, learning, and long-term cognitive function.